Oncotelic Therapeutics, Inc. financial data

Symbol
OTLC on OTC
Location
29397 Agoura Rd., #107, Aguora Hills, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 17, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.57 % +80.8%
Debt-to-equity 232 % +40.7%
Return On Equity -22.2 % +49.5%
Return On Assets -6.17 % +61.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 441M shares
Common Stock, Shares, Outstanding 439M shares +7.9%
Common Stock, Value, Issued 4.39M USD +7.9%
Weighted Average Number of Shares Outstanding, Basic 426M shares +4.7%
Weighted Average Number of Shares Outstanding, Diluted 453M shares +12.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 70K USD
Research and Development Expense 21.2K USD
General and Administrative Expense 690K USD +54.7%
Operating Income (Loss) -689K USD +81%
Nonoperating Income (Expense) -1.23M USD +4.78%
Net Income (Loss) Attributable to Parent -1.67M USD +64.2%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 409K USD +174%
Accounts Receivable, after Allowance for Credit Loss, Current 3.98K USD -79%
Assets, Current 1.61M USD +575%
Goodwill 2.79M USD 0%
Assets 28.2M USD +5.13%
Accounts Payable, Current 343K USD -82.4%
Liabilities, Current 20.1M USD +22.8%
Liabilities 20.1M USD +7.66%
Retained Earnings (Accumulated Deficit) -39.1M USD -4.46%
Stockholders' Equity Attributable to Parent 9.05M USD +2.24%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 8.08M USD -0.68%
Liabilities and Equity 28.2M USD +5.13%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -167K USD +27.9%
Net Cash Provided by (Used in) Financing Activities 160K USD -36%
Common Stock, Shares Authorized 750M shares 0%
Common Stock, Shares, Issued 439M shares +7.9%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -6.96K USD -137%
Interest Paid, Excluding Capitalized Interest, Operating Activities 94.8K USD 0%
Deferred Tax Assets, Valuation Allowance 12.8M USD -4.71%
Deferred Tax Assets, Gross 12.8M USD -4.71%
Deferred Tax Assets, Operating Loss Carryforwards 10M USD -4.43%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 15M shares 0%
Additional Paid in Capital 43.8M USD +3.66%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 0 USD
Interest Expense 885K USD -71.1%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%